Mellentin-Michelotti J, Evangelista L T, Swartzman E E, Miraglia S J, Werner W E, Yuan P M
PE Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA.
Anal Biochem. 1999 Aug 1;272(2):182-90. doi: 10.1006/abio.1999.4175.
We have developed a fluorescence-based mix and read method for the quantitative determination of receptor-ligand binding interactions. This method was used to determine IC(50) values for peptide ligands of two endogenous seven-transmembrane receptors that are expressed in cultured human cancer cells. Substance P, neurokinin A, and galanin were labeled with Cy5 and were shown to retain their native binding affinities. The cell-associated fluorescence was quantified using a fluorometric microvolume assay technology (FMAT) scanner that was designed to perform high-throughput screening assays in multiwell plates with no wash steps. The binding of fluorescently labeled substance P and neurokinin A was tested on the human astrocytoma cell line UC11 that expresses endogenous NK(1) receptor. Galanin binding was measured on endogenous galanin type 1 receptors in the Bowes neuroblastoma cell line. IC(50) values were determined for substance P, neurokinin A, and galanin and were found to correspond well with reported values from radioligand binding determinations. To demonstrate FMAT as instrumentation for high-throughput screening, it was utilized to successfully identify individual wells in a 96-well plate in which Cy5-substance P binding in UC11 cells was competed with unlabeled substance P. In addition, we developed a two-color multiplex assay in which cells individually expressing neuropeptide Y and substance P receptors were mixed in the same well. In this assay, the fluorescent ligands substance P and neuropeptide Y bound only to their respective cell types and binding was specifically competed. Therefore, two different seven-transmembrane receptor targets can be tested in one screen to minimize reagent consumption and increase throughput.
我们开发了一种基于荧光的混合读取方法,用于定量测定受体 - 配体结合相互作用。该方法用于测定在培养的人类癌细胞中表达的两种内源性七跨膜受体的肽配体的IC(50)值。P物质、神经激肽A和甘丙肽用Cy5标记,并显示保留其天然结合亲和力。使用荧光微量测定技术(FMAT)扫描仪对细胞相关荧光进行定量,该扫描仪设计用于在多孔板中进行高通量筛选测定,无需洗涤步骤。在表达内源性NK(1)受体的人类星形细胞瘤细胞系UC11上测试了荧光标记的P物质和神经激肽A的结合。在Bowes神经母细胞瘤细胞系的内源性1型甘丙肽受体上测量了甘丙肽结合。测定了P物质、神经激肽A和甘丙肽的IC(50)值,发现与放射性配体结合测定报告的值非常吻合。为了证明FMAT作为高通量筛选的仪器,利用它成功地在96孔板中识别出单个孔,其中UC11细胞中Cy5 - P物质的结合被未标记的P物质竞争。此外,我们开发了一种双色多重测定法,其中将单独表达神经肽Y和P物质受体的细胞在同一孔中混合。在该测定中,荧光配体P物质和神经肽Y仅与各自的细胞类型结合,且结合具有特异性竞争。因此,可以在一次筛选中测试两个不同的七跨膜受体靶点,以最小化试剂消耗并提高通量。